Charcot-Marie-Tooth disease, demyelinating, type 4C (often called CMT4C) is a rare inherited nerve disease that mainly affects the peripheral nerves, which are the long nerves going from the spinal cord to the arms, legs, and some parts of the face. In this condition the myelin, the “insulation layer” around the nerves, is damaged (this is what “demyelinating” means). Because the myelin is damaged, nerve signals travel more slowly and less strongly, which causes weakness, numbness, and problems with balance and walking. Genetic and Rare Diseases Center+2Orpha+2
Charcot-Marie-Tooth disease type 4C (CMT4C) is a rare inherited nerve disease that mainly affects the long nerves to the feet, legs, hands and arms. It is a demyelinating neuropathy, which means the “myelin coat” that protects nerves is damaged, so nerve signals travel more slowly and more weakly. Children often show problems early in life with high-arched or flat feet, walking difficulties, frequent falls, and early and sometimes severe curvature of the spine (scoliosis or kyphoscoliosis). CMT4C is caused by changes (mutations) in the SH3TC2 gene and is passed in an autosomal recessive pattern, so both parents usually carry one changed copy. There is no cure yet, and treatment focuses on rehabilitation, surgery for deformities, and good control of pain and daily function. ScienceDirect+4Genetic and Rare Diseases Center+4National Organization for Rare Disorders+4
CMT4C usually begins in childhood or early teenage years. Many children first show problems with the shape of their spine, such as scoliosis (curved spine) or kyphoscoliosis (forward and sideways curve), and with the shape of their feet, such as high arches or flat feet. Over time, the weakness and numbness slowly get worse, but most people have a normal life span. Genetic and Rare Diseases Center+2Orpha+2
The main medical cause of CMT4C is a harmful change (mutation) in a gene called SH3TC2. Every person has two copies of this gene. CMT4C happens when both copies are changed, one from each parent. This pattern is called autosomal recessive inheritance. Parents are usually healthy carriers and do not have symptoms. ScienceDirect+2Frontiers+2
Other names
Doctors and scientists use several other names for this same disease. Knowing these names helps when reading medical articles:
-
Charcot-Marie-Tooth disease type 4C (CMT4C) – the most common short name. Genetic and Rare Diseases Center+1
-
SH3TC2-related hereditary motor and sensory neuropathy (SH3TC2-HMSN) – name used in GeneReviews and genetics texts; it tells us that both movement (motor) and feeling (sensory) nerves are affected. NCBI+1
-
Autosomal recessive demyelinating Charcot-Marie-Tooth disease due to SH3TC2 – longer description that includes the inheritance pattern and the damaged myelin. Orpha+2Charcot-Marie-Tooth Association+2
-
AR-CMTde-SH3TC2 – a newer classification name, where “AR” means autosomal recessive, “CMTde” means demyelinating CMT, and SH3TC2 is the gene. Frontiers+1
-
SH3TC2-related Charcot-Marie-Tooth disease – another way to say that SH3TC2 is the main gene involved. Europe PMC+1
Types and classification
Charcot-Marie-Tooth disease is not one single disease. It is a group of many related genetic neuropathies. Doctors classify CMT into types based on nerve tests, inheritance, and genes: Charcot-Marie-Tooth Association+1
-
CMT1 – autosomal dominant demyelinating CMT (one changed copy of a gene, slow nerve conduction).
-
CMT2 – axonal CMT (the nerve fiber itself is damaged more than the myelin).
-
CMT4 – autosomal recessive demyelinating CMT (two changed copies of a gene, more severe in childhood).
-
CMTX – X-linked CMT where the changed gene is on the X chromosome.
Within CMT4, there are several subtypes such as CMT4A, 4B1, 4B2, 4C, 4D, 4E, 4F, 4G, 4H, and 4J, each linked to a different gene. CMT4C is one of these subtypes and is especially known for early and often severe spine deformity together with demyelinating neuropathy. NCBI+2Orpha+2
So, CMT4C means:
-
CMT = Charcot-Marie-Tooth disease
-
4 = autosomal recessive and demyelinating type
-
C = the specific subtype caused mostly by SH3TC2 gene mutations. Cell.com+1
Causes and risk factors
Medically, the true basic cause of CMT4C is a harmful change in both copies of the SH3TC2 gene. The 20 points below explain different aspects of this cause and factors that influence who gets the disease and how it looks.
-
Biallelic SH3TC2 mutations
CMT4C happens when a person has disease-causing mutations in both copies of the SH3TC2 gene (one from each parent). This “biallelic” change stops the gene from working normally and leads to demyelinating neuropathy. ScienceDirect+2Frontiers+2 -
Autosomal recessive inheritance
Because the condition is autosomal recessive, parents are usually healthy carriers with one changed and one normal copy. When both parents are carriers, each child has a 25% chance to have CMT4C, a 50% chance to be a carrier, and a 25% chance to have no mutation. Orpha+2NCBI+2 -
Nonsense mutations in SH3TC2
Some SH3TC2 mutations are “nonsense” mutations, which create a stop signal too early in the gene. This makes a shortened, non-working protein and strongly reduces myelin support in Schwann cells. Cell.com+1 -
Frameshift mutations
Frameshift mutations add or remove small pieces of DNA and change the reading frame of SH3TC2. This often leads to a very abnormal protein or no protein at all, again damaging the myelin around peripheral nerves. ScienceDirect+1 -
Missense mutations
Missense mutations change one amino acid in the SH3TC2 protein. Some of these changes disturb the protein’s shape or its ability to work in the cell’s membrane trafficking system, and this slowly harms the myelin sheaths. ScienceDirect+2OUP Academic+2 -
Splice-site mutations
Splice-site mutations affect how the SH3TC2 gene is cut and joined into mRNA. Poor splicing can remove important parts of the message or include wrong parts, leading to faulty protein and nerve damage. Cell.com+1 -
Large deletions or complex variants
In some patients, larger pieces of the SH3TC2 gene or nearby regions are missing or rearranged. These structural variants also remove normal protein function and cause a similar CMT4C picture. Frontiers+1 -
Founder mutations in specific populations
Certain communities or ethnic groups can share the same SH3TC2 mutation from a distant common ancestor (a “founder” mutation). This can make CMT4C more common in that group, even though it is rare overall. ScienceDirect+2ScienceDirect+2 -
Consanguinity (marriage between relatives)
When parents are related (for example, cousins), they are more likely to carry the same SH3TC2 mutation. This raises the chance that their children will inherit two changed copies and develop CMT4C. ScienceDirect+2ScienceDirect+2 -
Loss of SH3TC2 function in Schwann cells
SH3TC2 is mainly active in Schwann cells, the cells that make myelin in peripheral nerves. When SH3TC2 does not work, these cells cannot handle membrane recycling and myelin maintenance correctly, so myelin becomes thin and damaged. ScienceDirect+1 -
Demyelination leading to secondary axonal damage
Long-term myelin loss puts stress on the underlying nerve fibers (axons). Over time, some axons also degenerate, which further increases weakness and sensory loss, although CMT4C is classed as primarily demyelinating. NCBI+2ScienceDirect+2 -
Childhood onset during active growth
Because CMT4C often starts in the first decade, the disease affects nerves while the child is still growing. Weak muscles and abnormal nerve signals during growth contribute to early and sometimes severe spine and foot deformities. Genetic and Rare Diseases Center+2Orpha+2 -
Cranial nerve susceptibility
SH3TC2-related neuropathy can also affect some cranial nerves (for example, those to the face or tongue). This is not the basic cause but shows that SH3TC2 is important in many peripheral nerves, not just those to the arms and legs. NCBI+2NCBI+2 -
Genetic modifiers in other nerve genes
Some studies suggest that changes in other nerve or myelin genes may modify how severe CMT4C becomes. These extra genetic factors can explain why people with similar SH3TC2 mutations can have different levels of weakness or scoliosis. ScienceDirect+2Springer Link+2 -
Population differences in variant spectrum
Research shows that different countries and populations have different sets of SH3TC2 mutations. This means the exact mutation type can vary by region, which may slightly change how common the disease is and how it looks in each country. Frontiers+2ScienceDirect+2 -
Rare de novo mutations
Although most children inherit SH3TC2 mutations from both parents, in rare cases a new mutation can appear for the first time in the sperm or egg. This explains a few cases where there is no known family history. ScienceDirect+1 -
Limited awareness and delayed diagnosis
CMT4C is rare and not well known, so diagnosis is sometimes delayed. While this does not cause the gene change, it allows spinal deformities and contractures to progress without early treatment, making the physical problems more severe. ScienceDirect+2Digital Deposit UB+2 -
Lack of access to genetic testing
In some regions, genetic tests for SH3TC2 are not easily available. Families may not know they are carriers, which can lead to more affected children in the next generation, even though the underlying cause is still the recessive mutation. Charcot-Marie-Tooth Association+2ARUP Consult+2 -
Coexistence of other health problems
Conditions like poor nutrition or other chronic illnesses do not cause CMT4C but can worsen weakness and fatigue in someone who already has SH3TC2-related neuropathy, making the disease seem more severe. NCBI+2PM&R KnowledgeNow+2 -
Use of nerve-toxic medicines in carriers or patients
Some medicines are known to be toxic to peripheral nerves. In a person with CMT4C or a carrier, such drugs can further damage nerves and speed up symptoms. Guidelines for hereditary neuropathies recommend avoiding these drugs when possible. NCBI+2NCBI+2
Symptoms and signs
-
Early spinal deformity (scoliosis or kyphoscoliosis)
One of the most striking signs of CMT4C is early-onset spinal curvature. Children may develop scoliosis or kyphoscoliosis in the first decade of life, often before weakness is very obvious. The curve can become severe and may need bracing or surgery. Genetic and Rare Diseases Center+2Orpha+2 -
Weakness in feet and ankles
Many children have weak muscles around the ankles and feet. They may stumble, have trouble running, or walk more slowly than their peers. This happens because the motor nerves to the lower legs cannot send strong signals. NCBI+2NCBI+2 -
Foot deformities (pes cavus, flat feet, or valgus)
The shape of the feet often changes. Some people develop high arches (pes cavus), some have flat feet (pes planus), and some have heels that roll outward (pes valgus). These changes come from muscle imbalance and long-term nerve weakness. NCBI+2NCBI+2 -
Unsteady, high-stepping gait and frequent tripping
Because the front of the foot is weak, people may lift the knees higher to avoid dragging the toes. This is called a high-stepping gait. They may trip easily, especially on uneven ground or when they are tired. NCBI+2Cureus+2 -
Weakness in hands and fingers
Over time, CMT4C can also affect the nerves to the hands. People may notice difficulty with fine tasks, such as buttoning clothes, writing for a long time, or opening jars. This comes from distal hand muscle weakness and wasting. NCBI+2NCBI+2 -
Muscle wasting (atrophy) in legs and hands
When nerves cannot activate muscles correctly for a long time, the muscles become thinner and smaller. This is called atrophy. The calves and small muscles of the feet and hands often look wasted, giving the lower legs a “stork leg” appearance. NCBI+2PM&R KnowledgeNow+2 -
Reduced or absent tendon reflexes
Doctors often find that ankle and knee reflexes are weak or absent when they tap with a reflex hammer. This is common in demyelinating neuropathies and is an important clue to the diagnosis. NCBI+2News-Medical+2 -
Numbness and tingling (sensory loss)
Many people report a “pins and needles” feeling, burning, or numbness in the feet, and later in the hands. They may not feel sharp pain, temperature, or vibration well. This sensory loss increases the risk of unnoticed injuries. NCBI+2Europe PMC+2 -
Poor balance and sensory ataxia
Because the brain gets less information from the feet about position and movement, balance can be poor, especially in the dark or with eyes closed. People may sway when standing still, a sign called sensory ataxia. NCBI+2NCBI+2 -
Foot drop
Weakness of the muscles that lift the foot can cause foot drop, where the toes point downward when walking. This makes it hard to clear the ground and increases the risk of falls without braces or orthotics. NCBI+2ClinMed Journals+2 -
Fatigue and reduced endurance
Walking and standing need more effort when muscles are weak and joints are misaligned. Many people with CMT4C feel tired quickly and cannot walk long distances without resting, even if heart and lungs are otherwise healthy. PM&R KnowledgeNow+2Europe PMC+2 -
Pain or discomfort in feet, legs, or back
Some people have neuropathic pain (burning or shooting feelings), while others have pain from muscle overuse, joint strain, or scoliosis-related back pain. Pain levels vary widely between individuals. NCBI+2Mayo Clinic+2 -
Breathing problems in severe scoliosis
When the spinal curve is very large, the chest may not move freely. In severe cases this can lead to restricted lung function and shortness of breath, especially on exertion, and may need specialist care. NCBI+2NCBI+2 -
Cranial nerve symptoms (face, tongue, hearing, speech)
Some people with SH3TC2-related neuropathy have problems with facial weakness, tongue wasting, hearing loss, or slurred speech (dysarthria). These symptoms show that cranial nerves can also be involved in CMT4C, not just limb nerves. NCBI+2NCBI+2 -
Emotional and social impact
Living with a visible spine curve, walking difficulty, or need for braces can affect self-confidence, mood, school or work, and social life. Support from family, friends, and healthcare teams is important to help with anxiety or low mood. PM&R KnowledgeNow+2ScienceDirect+2
Diagnostic tests for CMT4C
Doctors do not rely on one single test. They combine history, physical examination, nerve tests, imaging, and genetic testing to confirm CMT4C and to rule out other causes of neuropathy.
Physical examination (general bedside assessment)
-
Detailed medical and family history
The doctor asks about the age when symptoms started, how they have changed, and whether any relatives have similar problems with walking, deformities, or nerve disease. Even when parents seem healthy, a pattern of affected siblings can suggest recessive CMT. Muscular Dystrophy Association+2News-Medical+2 -
Full neurological examination
The doctor tests muscle strength, tone, tendon reflexes, and coordination in arms and legs. Typical findings in CMT4C include distal weakness, reduced or absent reflexes, and sometimes signs of sensory ataxia. NCBI+2News-Medical+2 -
Gait and functional mobility assessment
The way a person walks (gait) is carefully observed. A high-stepping gait, foot drop, or difficulty walking on heels or toes suggests peripheral neuropathy. Simple timed walking tests can show how much function is limited. NCBI+2ClinMed Journals+2 -
Examination of feet and hands
The doctor looks for high arches, flat feet, hammer toes, calluses, and deformities, as well as muscle wasting in the feet and hands. These changes are common in hereditary neuropathies like CMT. NCBI+2News-Medical+2 -
Spine and posture examination
The back is inspected while standing and bending forward to detect scoliosis or kyphosis. In CMT4C, the spinal curve can be marked and may be one of the earliest signs, so careful spine examination is essential. Genetic and Rare Diseases Center+2Orpha+2
Manual bedside tests
-
Manual muscle testing (MRC grading)
The doctor gently resists the patient’s movements and grades strength, usually using the Medical Research Council (MRC) scale from 0 to 5. Distal muscles, such as ankle dorsiflexors and small hand muscles, are often weaker than proximal muscles in CMT4C. NCBI+2PM&R KnowledgeNow+2 -
Light touch and pin-prick sensory testing
Using cotton wool or a pin, the doctor compares feeling on different parts of the skin. Reduced sensation in a “stocking and glove” pattern (feet and hands first) strongly suggests a length-dependent peripheral neuropathy. NCBI+2News-Medical+2 -
Vibration and position sense testing
A vibrating tuning fork and gentle movement of toes or fingers are used to test vibration and joint position sense. Loss of these senses is common in demyelinating neuropathies and contributes to balance problems and sensory ataxia. NCBI+2PM&R KnowledgeNow+2 -
Romberg test and balance tests
In the Romberg test, the patient stands with feet together, first with eyes open, then closed. Increased swaying with eyes closed suggests sensory ataxia from poor feedback from the feet, which can happen in CMT4C. NCBI+2PM&R KnowledgeNow+2 -
Cranial nerve examination
The doctor checks facial movements, tongue strength and shape, hearing, and speech. In SH3TC2-related neuropathy, some patients show tongue atrophy, facial weakness, or hearing problems, so cranial nerve testing is important. NCBI+2NCBI+2
Laboratory and pathological tests
-
Targeted genetic testing for SH3TC2
Once a demyelinating neuropathy with early scoliosis is suspected, a blood sample can be tested for SH3TC2 mutations. Finding disease-causing changes in both copies of this gene confirms SH3TC2-related CMT4C. Europe PMC+2Frontiers+2 -
Next-generation sequencing (CMT gene panel or exome)
In many centers, a panel of many CMT genes or even whole-exome sequencing is used. This helps find SH3TC2 mutations and also checks for other inherited neuropathies when the diagnosis is not clear. ScienceDirect+2MDPI+2 -
Basic blood tests to rule out acquired neuropathy
Tests such as blood sugar, vitamin B12, thyroid function, kidney and liver function, and tests for infections or autoimmune disease help exclude other causes of peripheral neuropathy that can mimic CMT. NCBI+2Europe PMC+2 -
Nerve biopsy (usually sural nerve)
Today, nerve biopsy is used less often because genetic tests are better, but sometimes a small piece of nerve is removed and examined. In demyelinating hereditary neuropathies like CMT4C, the pathologist may see myelin damage and “onion bulb” formations from repeated demyelination and remyelination. Medscape eMedicine+2Digital Deposit UB+2 -
Cerebrospinal fluid (CSF) analysis in unclear cases
If doctors suspect an inflammatory neuropathy instead of CMT, they may do a lumbar puncture to test the fluid around the brain and spinal cord. Normal or mildly raised protein with no inflammation supports a hereditary neuropathy rather than an acquired one. Penn Medicine+2Medscape eMedicine+2
Electrodiagnostic tests
-
Nerve conduction studies (NCS)
In NCS, small electric pulses are given to nerves and the responses are recorded. In demyelinating CMT (including CMT4C), conduction velocities are slow and responses may be reduced. This pattern helps distinguish demyelinating from axonal types. Mayo Clinic+2NCBI+2 -
Electromyography (EMG)
EMG uses a thin needle electrode in muscles to record electrical activity. It can show signs of long-standing denervation and reinnervation, supporting the diagnosis of chronic peripheral neuropathy and helping to rule out motor neuron disease or myopathy. Mayo Clinic+2Medscape eMedicine+2 -
Quantitative sensory or evoked potential tests (in selected cases)
Some centers use tests like somatosensory evoked potentials or detailed quantitative sensory testing to measure how sensory signals travel. Abnormal results give more evidence of a long-standing sensory neuropathy in CMT. PM&R KnowledgeNow+2Europe PMC+2
Imaging tests
-
Spine X-rays
Simple X-rays of the spine are often done to measure the angle of scoliosis or kyphoscoliosis. In CMT4C, these images help decide whether bracing or surgery is needed and allow doctors to follow changes over time. Genetic and Rare Diseases Center+2Orpha+2 -
MRI or ultrasound of nerves and muscles (and sometimes spine)
MRI or ultrasound can show enlarged peripheral nerves and patterns of muscle wasting. Spine MRI may be used before surgery or if there are signs of spinal cord compression. These imaging tests support the diagnosis and help plan treatment, even though they are not always required. PM&R KnowledgeNow+2Radiopaedia+2
Non-Pharmacological Treatments (Therapies and Others)
These approaches are the foundation of CMT4C care. Evidence shows that physical therapy, orthotics and surgery for deformities are central, while drugs mainly reduce symptoms such as pain. PMC+2PMC+2
-
Individualized physical therapy program
A regular physical therapy plan with gentle strengthening, balance work and posture training helps you move more safely and stay active. The therapist adjusts exercises to your weakness pattern and scoliosis. The goal is to slow contractures, improve walking and reduce pain and fatigue in daily life, not to “cure” the disease. PMC+2Charcot-Marie-Tooth Disease+2 -
Stretching to prevent contractures
Slow, gentle stretching of ankles, calves, hamstrings, hands and spine helps keep joints flexible and reduces the risk of muscles becoming fixed in a tight position. In neuromuscular diseases like CMT, daily stretching can make walking, standing and dressing easier and may delay the need for surgery. Physiopedia+2Therapies for Inherited Neuropathies+2 -
Strength or resistance training
Carefully planned resistance training for weak muscle groups, especially ankle dorsiflexors and hand muscles, can improve strength and function without causing “over-work” damage. Programs are usually low-to-moderate intensity, 2–3 times per week, and supervised at the start. PMC+1 -
Endurance and aerobic exercise
Low-impact aerobic activities such as walking on flat ground, swimming or cycling help heart and lung fitness and reduce fatigue. For many people with CMT, better endurance also improves mood and sleep and may reduce pain sensitivity. Intensity must stay below the level that worsens symptoms. PMC+1 -
Ankle-foot orthoses (AFOs)
AFOs are braces for the lower leg and foot that help control foot drop, ankle instability and abnormal gait. They can increase walking speed, stride length and balance, and reduce the effort needed to walk and the risk of falls when chosen and fitted correctly. lermagazine.com+3ScienceDirect+3PubMed+3 -
Custom footwear and shoe inserts
Special shoes and insoles support high arches or flat feet, redistribute pressure and reduce pain and skin breakdown. For many people with CMT, proper footwear is a simple way to reduce foot pain and delay deformities or ulcers. Podiatry review is useful to adjust devices as the disease changes. PMC+2The Foundation for Peripheral Neuropathy+2 -
Occupational therapy (hand and daily-living training)
Occupational therapists teach strategies and tools to make everyday tasks easier, such as button hooks, pen grips and adapted cutlery. They may provide hand splints and specific exercises to keep fingers flexible and strong so that self-care, writing and phone use stay possible for longer. Charcot-Marie-Tooth Association+1 -
Spine-specific rehabilitation for scoliosis
In CMT4C, early scoliosis is common, so targeted exercises for trunk muscles, posture correction and breathing exercises are important. These programs aim to slow curve progression, improve comfort when sitting or walking and support lung function, especially in children and teenagers. Genetic and Rare Diseases Center+2ScienceDirect+2 -
Pain psychology and coping strategies
Chronic neuropathic pain often needs both medical and psychological tools. Cognitive-behavioural therapy, relaxation training and mindfulness can reduce the emotional burden of pain and improve sleep and mood. These approaches do not remove pain but help you regain control over daily life. PMC+1 -
Fall-prevention and home safety programs
Physiotherapists and occupational therapists can check your home for hazards and suggest simple changes like grab bars, non-slip mats, better lighting and stair rails. This helps prevent fractures, head injuries and fear of falling, which are major risks in CMT. Orthobullets+1 -
Hydrotherapy (water-based exercise)
Exercising in warm water supports the body and reduces joint load, so people with weakness can move more freely. This can improve stiffness, confidence and overall fitness while lowering the risk of falls during exercise. Charcot-Marie-Tooth Disease+1 -
Night splints for ankles and feet
Night-time splints hold the feet in a neutral position and can slow the development of fixed deformities and toe clawing. They may feel uncomfortable at first, so they are introduced gradually and adjusted frequently to avoid pressure sores. The Foundation for Peripheral Neuropathy+1 -
Hand and wrist splints
Light splints for the thumb and fingers can stabilize weak joints, improve grip and reduce pain during tasks like writing or using tools. They are usually combined with strengthening exercises and are adjusted as function changes. Mayo Clinic+1 -
Assistive walking devices (canes, walkers)
Canes or walkers are sometimes needed in later stages to keep walking safe. They widen the base of support, improve balance and may allow longer walking distances with less fatigue, especially when orthoses alone are not enough. Orthobullets+1 -
Breathing and coughing exercises
If scoliosis or muscle weakness affects breathing muscles, respiratory therapy can teach deep-breathing and assisted coughing techniques. This helps clear mucus, lowers infection risk and supports oxygen levels in more advanced cases. Genetic and Rare Diseases Center+1 -
Education and genetic counselling
Families benefit from learning how CMT4C is inherited and what genetic testing can show. Genetic counselling explains carrier status, risks to future children and research trials, and helps people make informed reproductive choices. PMC+2Europe PMC+2 -
School and workplace adaptations
Simple adaptations like extra time to walk between classes, elevator access, ergonomic desks and flexible work hours reduce strain and allow people with CMT4C to stay in school or work longer. Early communication with teachers and employers is important. Charcot-Marie-Tooth Disease+1 -
Psychological and peer support
Living with a chronic inherited disease can cause sadness, anxiety or low self-esteem. Counselling and patient-support groups give emotional help, share coping tips and reduce the feeling of being alone. PMC+1 -
Weight management and healthy lifestyle
Extra body weight increases stress on weak muscles and deformed joints, making walking and standing harder. A healthy diet and adapted exercise help control weight and reduce strain on feet, ankles and spine. Charcot-Marie-Tooth Disease+1 -
Regular multidisciplinary follow-up
Best care usually comes from a team: neurologist, physiatrist, physiotherapist, orthopaedic surgeon, orthotist, occupational therapist and sometimes pulmonologist and psychologist. Regular review allows early treatment of problems like new deformities or pain flares. PMC+2Orthobullets+2
Drug Treatments
There is no disease-modifying drug proven to stop or reverse CMT4C. Current medicines mainly treat neuropathic pain, muscle cramps, mood symptoms and sleep problems. Many of the drugs below are FDA-approved for neuropathic pain in other diseases (such as diabetic neuropathy or post-herpetic neuralgia), not specifically for CMT; use in CMT is usually “off-label”. NCBI+3PMC+3Charcot-Marie-Tooth Association+3
For each medicine, doses are typical adult ranges from FDA labels or neuropathic-pain guidelines; real doses, timing and duration must be chosen by a specialist, especially in children and teens. Best Practice Advocacy Centre+5FDA Access Data+5FDA Access Data+5
-
Gabapentin
Gabapentin is an anticonvulsant widely used for neuropathic pain. Adult neuropathic-pain dosing often ranges from about 900–3600 mg per day split into three doses, starting low and increasing slowly to reduce dizziness and sleepiness. It calms over-active nerve signalling by binding to calcium channels in nerve cells. Common side effects include drowsiness, weight gain and swelling of legs. Charcot-Marie-Tooth Association+4FDA Access Data+4FDA Access Data+4 -
Pregabalin
Pregabalin is a related gabapentinoid approved for several neuropathic pain conditions. Typical adult starting doses are around 150 mg per day, in two or three doses, with possible increase to 300–600 mg per day depending on response and tolerance. It reduces abnormal nerve firing and pain signals. Side effects include dizziness, blurred vision, weight gain, ankle swelling and sometimes mood changes. Charcot-Marie-Tooth Association+5FDA Access Data+5FDA Access Data+5 -
Duloxetine
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used for depression and chronic pain. For neuropathic pain, adult doses often start at 30–60 mg once daily. It boosts certain brain chemicals that modulate pain and mood. Common side effects include nausea, dry mouth, increased sweating and sometimes raised blood pressure. Best Practice Advocacy Centre+3Springer Link+3PMC+3 -
Venlafaxine (extended-release)
Venlafaxine XR is another SNRI sometimes used when duloxetine or gabapentin are not suitable. Doses for pain usually fall in the depression dose range (for example 75–225 mg daily), adjusted by the doctor. It enhances descending pain-control pathways. Side effects can include nausea, headache, insomnia, sweating and blood pressure elevation. Springer Link+2Charcot-Marie-Tooth Association+2 -
Amitriptyline
Amitriptyline is a tricyclic antidepressant (TCA) often used in low doses at night, such as 10–25 mg, with slow increases. It reduces nerve pain and also helps sleep. It works by blocking reuptake of serotonin and norepinephrine and by sodium-channel effects. Side effects: dry mouth, constipation, drowsiness, weight gain and possible heart rhythm problems at higher doses. Springer Link+2Best Practice Advocacy Centre+2 -
Nortriptyline
Nortriptyline is another TCA that may cause slightly fewer sedating and anticholinergic effects than amitriptyline. Low nightly doses (e.g., 10–50 mg) are commonly used for neuropathic pain, titrated slowly. It modulates pain by enhancing inhibitory neurotransmitters. Side effects can include dry mouth, dizziness and heart rhythm changes, so ECG monitoring may be needed. Springer Link+2Best Practice Advocacy Centre+2 -
Topical lidocaine 5% patch
Lidocaine patches are applied to painful skin areas for limited hours each day and act locally by blocking sodium channels in small sensory nerves. They can reduce burning or electric pain without many whole-body side effects. Skin irritation and numbness at the site are the main issues. Springer Link+2Charcot-Marie-Tooth Association+2 -
Topical capsaicin (low or high-concentration)
Capsaicin cream or patches reduce pain by desensitizing TRPV1 pain receptors in skin nerves. Initially, it can cause burning or stinging, but over time pain signals become weaker. Application schedules vary, and high-concentration patches must be applied in clinic. Springer Link+2Charcot-Marie-Tooth Association+2 -
Tramadol (short-term, selected cases)
Tramadol is a weak opioid with SNRI-like effects sometimes used for severe flares when other options fail. Doses are carefully limited because of risks of dependence, nausea, dizziness and seizures. It should be used for the shortest possible time and avoided in many young patients. Best Practice Advocacy Centre+2California Pain Consultants+2 -
Non-steroidal anti-inflammatory drugs (NSAIDs)
NSAIDs such as ibuprofen or naproxen do not treat neuropathic pain well, but can help with muscle ache, joint pain and post-surgical pain. They block cyclo-oxygenase enzymes and reduce inflammatory prostaglandins, but can irritate the stomach and kidneys with long-term use. Best Practice Advocacy Centre+1 -
Low-dose benzodiazepines (for severe muscle cramps – caution)
In some adults with very painful cramps, short-term low doses of benzodiazepines may be used, but these drugs cause dependence, drowsiness and falls. They are generally avoided in long-term management and in young people; non-drug strategies are preferred first. PMC+1 -
Sleep and mood medicines (e.g., SSRIs, melatonin – individualized)
Because chronic pain and disability can cause depression and insomnia, doctors may prescribe antidepressants or sleep aids. Choice depends on the full health picture, drug interactions and age. These medicines act on brain neurotransmitters or sleep-wake cycles and can indirectly improve pain coping and quality of life. PMC+2California Pain Consultants+2
(Other agents such as carbamazepine, lamotrigine, or combination therapies may be tried in complex cases, but evidence in CMT is limited and dosing must be strictly specialist-guided. Springer Link+2Best Practice Advocacy Centre+2)
Dietary Molecular Supplements
No supplement has been proven to cure or stop CMT4C, but some nutrients support general nerve and muscle health. Always discuss supplements with your doctor to avoid interactions and overdoses. PMC+2California Pain Consultants+2
-
Vitamin B12
Vitamin B12 is essential for myelin and nerve function. In people with low levels, replacement can improve nerve health and reduce neuropathy symptoms. Typical adult oral doses range from 500–1000 micrograms daily, but injection may be used in severe deficiency. Best Practice Advocacy Centre+1 -
Folate (Vitamin B9)
Folate works with B12 in DNA and myelin production. Correcting folate deficiency may help overall nerve function and blood health. Doses around 400–800 micrograms per day are common in adults, but higher doses need medical supervision, especially if B12 is low. Best Practice Advocacy Centre+1 -
Vitamin B1 (Thiamine)
Thiamine is important for energy production in nerve cells. Severe deficiency can cause neuropathy, so replacing low levels can prevent further damage. Supplement doses vary widely (e.g., 50–100 mg per day) depending on diet and medical history. Best Practice Advocacy Centre+1 -
Vitamin D
Vitamin D helps bone health and muscle function. Low vitamin D is common and can worsen muscle weakness and falls risk. Typical replacement doses might be 800–2000 IU daily in adults, adjusted after blood tests and medical advice. California Pain Consultants+1 -
Omega-3 fatty acids (fish oil)
Omega-3 fats have anti-inflammatory effects and may support cell membranes, including those in nerves. They are often taken as capsules providing EPA and DHA. Doses vary (for example 1–3 g per day), but can affect bleeding risk and must be checked with the doctor. California Pain Consultants+1 -
Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant studied in diabetic neuropathy. Some trials show reduced pain and improved nerve function with doses around 600 mg per day, though evidence in CMT is limited. It may cause stomach upset and affect blood sugar. California Pain Consultants+1 -
Coenzyme Q10 (CoQ10)
CoQ10 supports mitochondrial energy production. In some neuromuscular conditions, it is used as an adjunct to improve fatigue. Typical supplement doses range from 100–300 mg per day, but benefits in CMT4C specifically are not proven. California Pain Consultants+1 -
Magnesium
Magnesium is important for muscle relaxation and nerve function. If levels are low, supplements may help muscle cramps and general well-being. Usual oral doses are 200–400 mg elemental magnesium per day, adjusted to avoid diarrhoea. California Pain Consultants+1 -
Acetyl-L-carnitine
This compound helps energy production in mitochondria and has been studied in some neuropathies. Some data suggest possible pain reduction and nerve-conduction benefits, but evidence remains limited. Doses in studies vary from 500–1500 mg per day. California Pain Consultants+1 -
Multivitamin tailored by a dietitian
A balanced multivitamin/mineral chosen with a dietitian can fill dietary gaps without exceeding safe levels. The goal is overall health, not disease cure, and the exact formula should be adapted to age, kidney function and other medical issues. California Pain Consultants+1
Regenerative, Immunity-Related and Stem-Cell-Type Approaches
At present, there are no approved stem cell drugs or gene therapies for CMT4C. Research is ongoing, and some immune or gene-based strategies are being studied for other CMT types, mainly CMT1A. Any “regenerative” treatment should only be used inside regulated clinical trials. PMC+2Europe PMC+2
Examples of approaches under study (not standard care):
-
Gene therapy targeting SH3TC2
Experimental studies aim to correct or replace the faulty SH3TC2 gene in animal models or cell systems. The idea is to restore proper myelin support from Schwann cells. These methods are still pre-clinical or early-phase and not available as routine treatment. Europe PMC+2ScienceDirect+2 -
Neurotrophic-factor-based therapies
Molecules that support nerve survival (neurotrophic factors) are being tested to see if they can protect or regrow damaged peripheral nerves. Delivery methods include injections, viral vectors or modified cells. At present, these remain experimental and can carry risks such as abnormal nerve growth or immune reactions. PMC+1 -
Schwann-cell or stem-cell transplantation
Research groups are exploring transplantation of Schwann cells or stem-cell-derived nerve-supporting cells to improve myelination. These procedures are complex and risky, and so far have only been studied in small experimental settings, not routine CMT4C care. PMC+1 -
Immune-modulating medicines in misdiagnosed cases
Some acquired neuropathies respond to immune therapies such as IVIG or steroids, but hereditary CMT4C generally does not. These drugs are sometimes tried when diagnosis is uncertain, but once genetic CMT4C is confirmed, chronic immune suppression is usually not helpful and may be harmful. PMC+1 -
Clinical-trial drugs targeting myelin pathways
Several trial drugs aim to modify myelin biology in CMT, mostly CMT1A. They may act on PMP22 expression or other myelin proteins. People with CMT4C may be invited to trials in the future, but it is essential to join only registered, ethics-approved studies. PMC+1 -
Supportive immune-health measures (vaccinations, infection control)
While not “immunity booster drugs”, staying up to date with vaccines, treating infections early and maintaining good hygiene protect people whose mobility is limited and lungs may be compromised by scoliosis. This reduces complications and hospitalizations. PMC+1
Surgeries (Procedures and Why They Are Done)
Surgery in CMT4C focuses on deformities, not on nerves themselves. It is usually considered when braces and therapy are no longer enough to keep feet or spine functional and comfortable. OrthoInfo+5PMC+5Charcot-Marie-Tooth Disease+5
-
Foot soft-tissue releases and tendon transfers
Surgeons may lengthen tight tendons or move tendons from stronger muscles to weaker ones to rebalance the foot. This can correct cavus (high-arched) or clawed toes and improve walking, shoe fit and pain. -
Foot osteotomies (bone cuts)
In more rigid deformities, surgeons cut and reposition bones in the foot to achieve a more plantigrade (flat) position. This improves weight distribution, reduces calluses and ulcers, and can make brace use easier. -
Triple arthrodesis (fusion of hindfoot joints)
When deformity is severe and inflexible, fusing three joints in the hindfoot can create a stable, painless foot that can bear weight. It sacrifices some mobility but improves stability and shoe wear in advanced cavovarus deformity. -
Spinal fusion for scoliosis or kyphoscoliosis
In children or teens with rapidly progressing spinal curves, fusion surgery may be recommended to prevent further deformity and protect lung function. Metal rods and screws hold the spine in a straighter position while the bones fuse. -
Tendon-lengthening procedures (e.g., Achilles lengthening)
Short, tight Achilles tendons and calf muscles can cause toe-walking and poorer balance. Lengthening procedures aim to allow the heel to contact the ground more easily, improving gait, brace fitting and reducing falls.
Prevention and Lifestyle Protection
You cannot prevent the genetic cause of CMT4C, but you can reduce complications: nhs.uk+3PMC+3Orthobullets+3
-
Stay in a regular, safe exercise and stretching program.
-
Use braces, splints and orthotics as prescribed and keep them well-fitted.
-
Protect feet with well-fitting shoes; check skin daily for blisters or sores.
-
Avoid high-risk sports with jumping, twisting or heavy contact that increase injury risk.
-
Keep body weight as healthy as possible to reduce stress on weak muscles and joints.
-
Do not smoke, because smoking harms blood flow to nerves and tissues.
-
Manage other diseases (diabetes, vitamin deficiencies) that can worsen neuropathy.
-
Keep vaccinations up to date and treat chest infections promptly, especially with scoliosis.
-
Have regular follow-up with neuromuscular and orthopaedic teams to catch problems early.
-
Offer genetic counselling to family members so they can understand and plan for risk.
When to See Doctors
You should see a neurologist and your CMT team regularly, even if you feel stable. Make an urgent appointment or seek emergency care if you notice:
-
Sudden worsening of weakness, falls or new difficulty walking.
-
Rapid change in spine curve, new back pain or breathing problems.
-
New severe or burning pain, numbness, or loss of bladder or bowel control.
-
Signs of foot infection: redness, warmth, swelling, open sores that do not heal.
-
Serious side effects of medicines: severe rash, swelling of face, trouble breathing, chest pain, suicidal thoughts, or strong mood changes (these are listed in many neuropathic-pain drug labels). Springer Link+4FDA Access Data+4FDA Access Data+4
Regular reviews help adjust therapy, braces and drugs so that function and safety stay as good as possible. PMC+2Orthobullets+2
What to Eat and What to Avoid
A special “CMT4C diet” does not exist, but good nutrition supports muscles, nerves and bones. California Pain Consultants+1
Helpful to eat:
-
Plenty of fruits and vegetables for vitamins, minerals and antioxidants.
-
Whole grains (brown rice, oats, whole-wheat bread) for steady energy.
-
Lean proteins (fish, eggs, beans, poultry) to support muscle repair.
-
Healthy fats from fish, nuts, seeds and olive oil.
-
Calcium- and vitamin-D-rich foods (dairy or fortified alternatives) to support bones.
Better to limit or avoid:
- Sugary drinks and sweets that add empty calories and weight.
- Very salty fast foods that can worsen swelling and blood pressure.
- Excess saturated and trans fats from deep-fried and processed foods.
- Alcohol, which can damage nerves and interact with many pain medicines.
- Very high doses of “natural” supplements without medical supervision, as these can interact with prescriptions or harm the liver or kidneys.
Frequently Asked Questions (FAQs)
-
Is CMT4C life-threatening?
CMT4C usually causes long-term disability rather than sudden death. Many people live a normal lifespan but may need braces, surgery and walking aids. Severe spine deformities or breathing problems can be serious, so regular monitoring is important. Genetic and Rare Diseases Center+2National Organization for Rare Disorders+2 -
Can CMT4C be cured?
At the moment there is no cure and no approved drug that stops the gene problem. Treatment focuses on rehabilitation, surgery for deformities and good pain management to keep independence and quality of life as high as possible. PMC+2ScienceDirect+2 -
Is CMT4C the same as other CMT types?
CMT4C is one of many CMT types and is specifically a demyelinating, autosomal recessive form linked to SH3TC2. Symptoms overlap with other CMTs, but gene cause, age of onset and spine deformity pattern can differ. PMC+2Charcot-Marie-Tooth Association+2 -
Will my children definitely have CMT4C?
Because CMT4C is recessive, each child of two carriers has a 25% chance to be affected, 50% chance to be a carrier, and 25% chance to inherit no changed gene. Genetic counselling and testing help clarify risks for your family. PMC+2Europe PMC+2 -
Can exercise make CMT4C worse?
Too much or wrong kind of exercise may cause over-fatigue or injury, but well-planned, low-impact training supervised by therapists usually helps maintain strength and mobility and is considered safe in studies. PMC+2ScienceDirect+2 -
When is surgery necessary?
Surgery is considered when deformities, like severe cavus feet or scoliosis, cause pain, frequent falls, shoe problems or breathing issues and when braces and therapy are no longer enough. The decision is individual and made with an experienced orthopaedic team. OrthoInfo+3PMC+3Charcot-Marie-Tooth Disease+3 -
Will braces make my muscles weaker?
Properly prescribed AFOs and orthotics aim to support weak muscles, improve gait and reduce falls. Studies show they can improve walking, although they must be balanced with ongoing exercises to keep muscles as active as possible. lermagazine.com+3ScienceDirect+3PubMed+3 -
Are pain medicines safe for long-term use?
Many neuropathic pain medicines can be used long term with regular monitoring, but all have side effects. Doctors try to use the lowest effective dose, review regularly and combine drugs with non-drug strategies to minimize risks. FDA Access Data+3Springer Link+3FDA Access Data+3 -
Should I try experimental stem-cell or gene therapies abroad?
Unregulated “stem-cell clinics” can be very dangerous and expensive, with little proof of benefit. Experts recommend joining only properly controlled, ethics-approved clinical trials, usually listed through academic centres or official registries. PMC+2ScienceDirect+2 -
Does diet change the course of CMT4C?
Diet cannot change the gene problem, but healthy food, good weight control and enough vitamins (especially B-vitamins and vitamin D) support muscles and bones and may reduce complications like fractures and fatigue. California Pain Consultants+1 -
Can CMT4C affect hearing or vision?
Some CMT4 cases, and other demyelinating CMT types, may have additional problems such as hearing loss or eye movement difficulties. Any new hearing or vision issues should be checked by specialists. Charcot-Marie-Tooth Association+2PMC+2 -
Is pregnancy safe if I have CMT4C?
Many people with CMT have safe pregnancies, but extra planning is needed. Weakness, balance problems and spine deformity may complicate late pregnancy, delivery and anaesthesia choices. Pre-pregnancy counselling with neurology and obstetrics is important. PMC+1 -
Will CMT4C spread to my brain or organs?
CMT4C affects peripheral nerves, not the brain itself, and usually does not “spread” to internal organs. However, scoliosis can affect lungs, and limited mobility can affect heart and metabolic health over time, so regular check-ups are essential. Genetic and Rare Diseases Center+2PMC+2 -
How early should children start therapy?
Because CMT4C often starts in childhood, early assessment and treatment are important. Starting physical and occupational therapy, bracing and spine monitoring early may delay deformities and support better lifelong function. Orthobullets+3Genetic and Rare Diseases Center+3National Organization for Rare Disorders+3 -
Where can families find reliable information and support?
Neuromuscular clinics, national CMT organizations, muscular-dystrophy associations and official rare-disease websites provide trustworthy information, research updates and peer-support networks. These groups also help families learn about clinical trials and rehabilitation resources. Muscular Dystrophy Association+2Charcot-Marie-Tooth Disease+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 30, 2025.